Braille, Voice-Enabled QR Codes & More: Govt To Set Up Panel To Revamp Medicine Labelling
Last Updated:
The concerns submitted to the govt include issues like expiry dates being printed on easily torn paper, reflective surfaces making labels unreadable, and text size being too small.
Get ready for voice-assisted QR codes, braille cards, and clearer labels on your medicine strips — the central government is planning a major overhaul of drug packaging to make medicines more patient-friendly, News18 has learnt.
To address consumer complaints about the labelling of medicinal products and to make medicine packaging more inclusive for the visually impaired, the drug regulatory agency, Central Drugs Standard Control Organisation (CDSCO), is set to constitute an expert panel.
Acting on recommendations from the Drug Consultative Committee (DCC), the CDSCO will now form a sub-committee to examine packaging-related concerns in detail.
'DCC was apprised that various concerns have been received from the consumers in their public grievances from time to time with respect to the labelling of medicinal products," said the government document sent to states and union territories for execution, seen by News18.
The concerns submitted to the central government include issues such as expiry dates being printed on easily torn paper, reflective surfaces making labels unreadable, and text size being too small.
The concerns submitted to DCC – which discussed the matter in the meeting dated 17 June – also include inconsistent printing of medicine names (only at one place on the entire strip) and the need for a universal symbol to clearly distinguish generic medicines from branded ones.
'The proposed sub-committee will discuss these concerns in detail," said the government official, while adding the panel has asked to include at least one packaging expert and will evaluate whether new regulatory standards are needed for suppliers of packaging materials under the Drugs Rules, 1945. 'The industry is expected to create a pushback as any change in labelling leads to heavy capital expenditure on their end. However, the final move will be decided by the proposed panel."
Blind friendly medicine packaging
In a related move to improve patient convenience, the DCC also recommended measures to help blind and visually impaired individuals identify medicines.
Discussing the proposal regarding the problems faced by the blind or visually impaired people in reading medicines, tablets or capsule strips, DCC was apprised that a similar deliberation was done earlier by the expert panel, which had earlier recommended constituting a panel to examine the issue. Accordingly, that panel had submitted its report. The same report was discussed in the meeting, and now, it will be made public and open for comments, along with the two new suggestions.
These include adding braille cards to secondary packaging of medicines containing more than 10 units, and integrating QR codes with voice-assistance features on drug labels.
'Secondary packaging containing more than 10 units of medicines may have some braille cards for giving to such population as and when required," said the first suggestion, while adding the second recommendation stating, 'Medicines can have a QR code linked with voice assistance."
Experts believe that, if executed, these developments will mark a significant step towards improving patient safety, accessibility, and transparency in India's pharmaceutical packaging practices.
First Published:
June 27, 2025, 10:06 IST
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
13 hours ago
- News18
Braille, Voice-Enabled QR Codes & More: Govt To Set Up Panel To Revamp Medicine Labelling
Last Updated: The concerns submitted to the govt include issues like expiry dates being printed on easily torn paper, reflective surfaces making labels unreadable, and text size being too small. Get ready for voice-assisted QR codes, braille cards, and clearer labels on your medicine strips — the central government is planning a major overhaul of drug packaging to make medicines more patient-friendly, News18 has learnt. To address consumer complaints about the labelling of medicinal products and to make medicine packaging more inclusive for the visually impaired, the drug regulatory agency, Central Drugs Standard Control Organisation (CDSCO), is set to constitute an expert panel. Acting on recommendations from the Drug Consultative Committee (DCC), the CDSCO will now form a sub-committee to examine packaging-related concerns in detail. 'DCC was apprised that various concerns have been received from the consumers in their public grievances from time to time with respect to the labelling of medicinal products," said the government document sent to states and union territories for execution, seen by News18. The concerns submitted to the central government include issues such as expiry dates being printed on easily torn paper, reflective surfaces making labels unreadable, and text size being too small. The concerns submitted to DCC – which discussed the matter in the meeting dated 17 June – also include inconsistent printing of medicine names (only at one place on the entire strip) and the need for a universal symbol to clearly distinguish generic medicines from branded ones. 'The proposed sub-committee will discuss these concerns in detail," said the government official, while adding the panel has asked to include at least one packaging expert and will evaluate whether new regulatory standards are needed for suppliers of packaging materials under the Drugs Rules, 1945. 'The industry is expected to create a pushback as any change in labelling leads to heavy capital expenditure on their end. However, the final move will be decided by the proposed panel." Blind friendly medicine packaging In a related move to improve patient convenience, the DCC also recommended measures to help blind and visually impaired individuals identify medicines. Discussing the proposal regarding the problems faced by the blind or visually impaired people in reading medicines, tablets or capsule strips, DCC was apprised that a similar deliberation was done earlier by the expert panel, which had earlier recommended constituting a panel to examine the issue. Accordingly, that panel had submitted its report. The same report was discussed in the meeting, and now, it will be made public and open for comments, along with the two new suggestions. These include adding braille cards to secondary packaging of medicines containing more than 10 units, and integrating QR codes with voice-assistance features on drug labels. 'Secondary packaging containing more than 10 units of medicines may have some braille cards for giving to such population as and when required," said the first suggestion, while adding the second recommendation stating, 'Medicines can have a QR code linked with voice assistance." Experts believe that, if executed, these developments will mark a significant step towards improving patient safety, accessibility, and transparency in India's pharmaceutical packaging practices. First Published: June 27, 2025, 10:06 IST
Time of India
a day ago
- Time of India
Plans to restrict open market access to tuberculosis medicines
With cases of drug-resistant tuberculosis on the rise in India, authorities are set to tighten open market access to newer anti-TB drugs Bedaquiline and Delamanid , which went off patent last year. The Central TB division-which is under the health ministry-had written to the Central Drugs Standard Control Organisation (CDSCO) citing "access risks" that are leading to indiscriminate use, potentially increasing cases of treatment failure and resistance to these drugs. The patents for Bedaquiline and Delamanid expired last year, paving the way for pharmaceutical companies to manufacture the molecule. The drugs eventually became available in the market. The newer anti-TB drugs, including Bedaquiline, Delamanid, Pretomanid and Rifapentine, are available in the market. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Chuck Norris Begs Seniors: Avoid These 3 Foods Like The Plague Roundhouse Provisions Learn More Undo This week, the matter was taken up by the Drugs Consultative Committee (DCC), an expert committee under the CDSCO, which suggested that licences be issued on the condition that the use of Bedaquiline, Delamanid, Pretomanid and Rifapentine will be as per Standards of TB Care in India (STCI), and that there should be conditional access through the National TB Elimination programme (NTEP). The experts also said that if such a condition is not mentioned in the existing licences, it should be modified accordingly. It also said the label on the container of the drug, as well as the packaging, should bear the warning-"For use in NTEP", which shall be in a box with a red background. Live Events "The DCC, after detailed deliberation, agreed with the proposal to issue suitable guidance to all state licensing authorities to address the issue uniformly. The DCC also recommended that in case some SLAs had already issued the manufacturing licence for such a product, they can issue separate letters for communicating the above conditions," the minutes of the meeting suggested. ET has seen a copy of the minutes.
Time of India
a day ago
- Time of India
Govt to bring in barcodes to fight fake drug menace
In a bid to weed out spurious drugs , manufacturers of antimicrobials, narcotic drugs, vaccines, and psychotropic substances will have to mandatorily affix barcodes or quick response (QR) codes on their product labels. The Union health ministry is set to shortly amend the drug rules for implementing this measure, people in the know told ET. The proposal to affix barcodes has been in the works for long, though it faced opposition from various stakeholders. A consultative meeting was held last month wherein the stakeholders raised their concerns. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Has Toyota Done It Again? The New RAV4 Is Finally Here (Take A Peek) FrequentSearches | Search Ads Learn More Undo However, the Drugs Consultative Committee (DCC) under the Central Drugs Standard Control Organisation (CDSCO) in a meeting this Tuesday deliberated and opined that the stakeholder concerns do not appear to be "substantial" in public interest and agreed to appropriately amend the Drugs Rules, 1945, according to the minutes of the meeting a copy of which was seen by ET. Live Events Earlier, the drug regulator had included a few cancer drugs to mandatorily have barcodes for validating their authenticity following incidents of refilling of expensive anti-cancer drugs by criminals with counterfeits. Criminals in collusion with hospital pharmacies were found refilling empty vials of expensive anti-cancer medicines with counterfeit drugs. These fake drugs were then mixed with genuine stocks and sold to unsuspecting cancer patients, putting their lives at risk. The regulator had made it mandatory for companies to have barcodes on the top 300 brands, so that information such as manufacturing licence and batch number can be accessed upon scanning. These drugs include widely-used analgesics, pain relievers, anti-platelet, vitamin supplements, blood-sugar lowering medicines and contraceptive tablets. "The move was to ensure authenticity of drugs and enable tracing," said a government official, on the condition of anonymity. Brands identified by the National Pharmaceutical Pricing Authority include Dolo, Saridon Fabiflu, Ecosprin, Limcee, Sumo, Calpol, Corex syrup, Unwanted 72, and Thyronorm. They were shortlisted based on their moving annual turnover value based on data from market researcher Pharmatrac. The government had been trying to introduce QR codes since 2011. It however couldn't proceed with the plan following concerns by pharma companies and lobby groups, before it was eventually implemented in 2023.
